Making diagnostics better.

MicroPhage delivers high-value bacterial diagnostics for identification and antibiotic testing – providing critical knowledge and enabling better treatment when and where it is needed.

Faster results. Expanded menus. Easy-to-use formats. That's how MicroPhage is revolutionizing bacterial screening, identification, and antibiotic susceptibility testing.

At the core of our success is a proprietary technology that enables specific identification of bacteria and direct antibiotic susceptibility and resistance testing – straight from samples and cultures.

MicroPhage's technology uses bacteriophage amplification to produce a specific and highly antigenic marker to identify the presence of viable bacteria and their response to antibiotics. This process offers the ability to increase specificity and decrease time to results on existing immunodiagnostic platforms.

Unlike molecular testing, phage amplification does not require technical expertise or sophisticated equipment to drive or measure results. Our proprietary technology can deliver "better than molecular" results almost anywhere – reducing your costs and increasing your margins.